Introduction {#s1}
============

Stress elicits many neural and endocrine changes, including activation of the hypothalamic--pituitary--adrenal (HPA) axis. Activation of this axis, in turn, stimulates secretion of glucocorticoid hormones (corticosterone and/or cortisol), which have numerous physiological consequences. Although acute HPA activation stimulates processes that increase the likelihood of survival, chronic stress is generally associated with negative outcomes ([@COV022C35]; [@COV022C20]; [@COV022C27]; [@COV022C12], [@COV022C13]; [@COV022C48]; [@COV022C29]).

Adverse consequences of chronic HPA activation can include effects on immune function. While acute glucocorticoid elevations may stimulate immune cell production, chronically elevated glucocorticoid concentrations often suppress cytokine synthesis, leucocyte mobilization and other immune-promoting reactions (reviewed by [@COV022C20]; [@COV022C27]; [@COV022C41]). Consequently, chronic HPA activation may lead to immunosuppression. In amphibians, for example, studies have linked long-term exposure to environmental stressors, such as agrochemicals ([@COV022C18]; [@COV022C28]), and extreme environments, such as arid climates ([@COV022C23]), to parasitic (e.g. trematode) infection and fitness ([@COV022C15]; [@COV022C18]; [@COV022C38]; [@COV022C44]).

Prolonged stimulation of the HPA axis can also lead to numerous other adverse outcomes for animals. For example, chronically increased glucocorticoid concentrations suppress reproductive behaviour in a variety of taxa ([@COV022C33]; [@COV022C32]) and may also mediate suppression of reproductive physiology ([@COV022C34]; [@COV022C3]; [@COV022C47]; [@COV022C16]; [@COV022C43]).

In light of the current status of declining amphibian populations ([@COV022C4]; [@COV022C45]; [@COV022C19]), an understanding of the effects of chronic environmental stress on the physiology of these animals is of particular interest. Despite the well-established detrimental effects in many other taxa ([@COV022C26]; [@COV022C41]; [@COV022C52]), however, the potential adverse effects of chronic stress on amphibians have been largely overlooked. Some studies have examined the correlation between amphibian stress and the effects of human encroachment on habitat (e.g. the introduction of pesticides or pollution and the spread of diseases; [@COV022C36]; [@COV022C14]; [@COV022C25]), and recently, [@COV022C21], [@COV022C22]) have examined the effect of substrate (as a proxy for matrix habitat) and habitat availability on stress hormones. [@COV022C46] reported that noise led to increased circulating corticosterone and altered mate choice. Recently, [@COV022C24] found that exposing frogs to an anthropogenic stressor (traffic noise) over a 7 day period led to increases in circulating corticosterone concentrations as well as significant decreases in sperm count and sperm viability. However, the mechanism for this suppression was not investigated. Models from other vertebrates suggest corticosterone as a likely candidate to mediate reproductive suppression. In the present study, therefore, we measured the effects of chronic treatment with exogenous corticosterone on the amphibian reproductive system using male White's treefrogs (*Litoria caerulea*). Given that a chronic increase in corticosterone is frequently associated with immunosuppresion, we also tested the effects of chronic exogenous corticosterone application on immune cell counts. We predicted that animals exposed to high concentrations of exogenous corticosterone for 1 week would show decreases in sperm count and sperm viability, similar to our previous findings ([@COV022C24]), and would also show decreases in circulating lymphocyte counts and splenic cell counts.

Materials and methods {#s2}
=====================

Animals and experimental design {#s2a}
-------------------------------

Twenty captive-bred adult male White's treefrogs were acquired from a North American breeder and individually housed in plastic tanks measuring approximately 40 cm × 24 cm × 32 cm (Kritter Keepers, size XL, San Marcos, CA, USA). This species has been used widely in physiological and ecological studies ([@COV022C6]; [@COV022C2]; [@COV022C10]; [@COV022C51]; [@COV022C53]; [@COV022C49]; [@COV022C24]). Frogs were given dechlorinated tap water that was changed daily and were fed three or four medium-sized crickets twice weekly. All crickets were removed 24 h prior to blood collection. Lighting and temperature were controlled on a 12 h--12 h light--dark cycle (lights on at 09.00 h) and at 21--23°C, respectively. Tanks included a 10 cm length of PVC pipe for enrichment. The study was conducted during the North American breeding season for this species (from 6 August to 2 September 2012). All procedures were approved by the University of California, Riverside Institutional Animal Care and Use Committee Protocol A-20100040. The University of California, Riverside is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care.

Frogs were divided into three treatment groups: two control groups \[undisturbed control (UC) and blood-sampled control (BC)\] and a corticosterone-treated experimental group (CORT). The two control groups allowed us to obtain data from animals that were not manipulated during the period of data collection as well as from animals that did not undergo treatment but for which we obtained measures of plasma corticosterone concentrations at all time points for which we had comparable measures from CORT animals.

Blood sampling and exogenous 'corticosterone application {#s2b}
--------------------------------------------------------

To elevate circulating corticosterone concentrations, we used the dermal patch method developed for use in amphibians ([@COV022C50]). Based on preliminary data (K. Kaiser, unpublished data), we prepared a 20 mg/ml solution of corticosterone (92% pure, C2505; Sigma Aldrich, St Louis, MO, USA), which was suspended in sesame oil (unrefined expeller pressed; Whole Foods Market, Austin, TX, USA). Dermal patches were filter-paper pieces ∼5 mm in diameter (FisherBrand Filter Paper, P8, Pittsburgh, PA, USA). We applied 7 µl of the corticosterone solution to patches applied to the dorsal trunk region of CORT frogs for a dose of 140 µg per corticosterone treatment. Patches remained in place for 1 h, and treatment was repeated every 8 h for 7 days. We chose a chronic exposure of 7 days to replicate the exposure duration of the study by [@COV022C24], in which significant reproductive effects were observed. During lights-off periods, applications were performed under red lights to avoid interference with circadian rhythms. Frogs were monitored periodically during the hour that patches were in place. In a few cases, frogs removed patches; when this occurred, we immediately reapplied the patch.

We collected blood from CORT and BC animals at three time points: day −5 (5 days before CORT treatment began in CORT animals), day 4 (4 days after CORT application began in CORT animals on day 0) and day 7 (the end of the study). Blood was collected from UC animals only on days −5 and 7.

On days −5 and 4, blood was collected via cardiac puncture as in the study by [@COV022C24]. Frogs were treated with a topical antibiotic, and blood was collected using a sterile 27-gauge needle and a 1 ml syringe. On day 7, animals were killed by decapitation followed by double pithing, and blood and organs (see below) were harvested. At all time points, blood was collected within 3 min of initial disturbance to the animal. At each time point, we were unable to collect samples from some individuals, so these data are missing. Samples were taken at 12.30--13.30 h, ∼4.5 h after the most recent application of exogenous corticosterone. This time frame was chosen to allow animals time to metabolize the exogenous corticosterone from the most recent experimental application and to minimize differences due to diel rhythms in baseline corticosterone. Blood was centrifuged for 12 min at 13.3 ***g*** at 4°C, and plasma was extracted and stored at −80°C until assayed for corticosterone.

Corticosterone assay {#s2c}
--------------------

We measured plasma corticosterone concentrations using a double-antibody ^125^I-radioimmunoassay kit (MP Biomedicals, Costa Mesa, CA, USA) previously validated in our laboratory for this species ([@COV022C24]). Samples were extracted and assayed in duplicate in two assays. Assay sensitivity was 50.4 pg/ml. The intra-assay coefficient of variation (CV) of an internal control plasma pool at the low end of the standard curve (83% bound) sampled in duplicate was 1.6%; interassay CV of this pool was 1.4%. The intra-assay CV of an internal pool at the high end of the standard curve (26% bound) was 8.0%; interassay CV of this pool was 5.0%.

Reproductive measures {#s2d}
---------------------

The right testis was collected from each frog, and sperm were collected and labelled as described by [@COV022C24]. Briefly, we minced the testis in 5 ml of 0.1 M phosphate-buffered saline and incubated it at room temperature for 1 h to allow sperm to separate from the testicular tissue. Total sperm count was measured as the average of duplicate counts for each testis on a haemocytometer loaded with sample in a 10% solution of Trypan blue (Thermo Scientific, Logan, UT, USA).

For analysis of sperm viability, we used the same protocol as [@COV022C24]. Sperm were centrifuged at 1000***g*** for 5 min at 4°C. Cells were washed with FACS buffer (phosphate-buffered saline containing 0.5% bovine serum albumin and 2 mM EDTA) and labelled using CellTrace™ CFSE Cell Proliferation Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions (2 µl/ml cells from 5 mM stock solution for 10 min). Cells were further treated with Fixable Viability Dye eFluor^®^ 660 (eBioscience, San Diego, CA, USA) according to the manufacturer's instructions (1 µl of undiluted dye/ml cells for 30 min). Cells were then fixed with 500 µl of 4% paraformaldehyde in FACS buffer and stored at 4°C for later analysis with a BD FACSCantoII flow cytometer (BD Biosciences, San Jose, CA, USA).

Immune measures {#s2e}
---------------

### Blood smears and white blood cell count {#s2e1}

We collected two blood smears from each frog immediately after they had been killed on day 7. Smears were stained with haematoxylin and eosin, photographed at ×40 magnification, and counted using the ImageJ Cell Counter plugin (ImageJ v. 1.46r; NIH, available at <http://imagej.nih.gov/ij>). A minimum of three investigators blinded to sample treatments counted each smear. Prior to counting images for the experiment, all investigators were trained and tested on a set of images not included in this study. Cell types were distinguished based on characters described and illustrated by [@COV022C9] and [@COV022C17]. Each investigator counted the number of each type of white blood cell (WBC: eosinophils, neutrophils and lymphocytes) from among at least 500 erythrocytes (RBCs). Other WBCs were encountered infrequently and not counted. We used the mean counts from all three scorers for analysis; any outlier counts were rescored. We calculated the ratio of each type of WBC to RBCs and the ratio of neutrophils to lymphocytes ([@COV022C53]; [@COV022C11]).

### Spleen cell count {#s2e2}

Spleens were harvested immediately after animals had been killed and placed in cRPMI media (RPMI media; Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum, [l]{.smallcaps}-glutamine, penicillin--streptomycin antibiotic, Hepes, sodium pyruvate, non-essential amino acids and 2-β-mercaptoethanol) on ice. Splenic cell suspensions were prepared by straining cells through 40 μm nylon filters (Fisher Scientific, Pittsburgh, PA, USA) and rinsing with cRPMI media. Cells were centrifuged at 300 *g* for 5 min at 4°C; supernatant was discarded, and each cell pellet was resuspended in ACK Lysing Buffer (Lonza, Walkersville, MD, USA) for 5 min on ice. Cells were washed three times with cRPMI media. The final cell pellet was resuspended in 1 ml of cRPMI media. A subsample of the cell suspension was labelled with a 10% solution of Trypan blue (Thermo Scientific) and counted in duplicate on a haemocytometer.

Data analysis {#s2f}
-------------

We used FlowJo (v. 8.7.3; TreeStar, Ashland, OR, USA) for analysis of flow cytometry data, SPSS 18.0.0 (PASW Inc., Hong Kong) for analysis of corticosterone data, and StataIC (v. 10; StataCorp, College Station, TX, USA) for all other statistical analyses. All data were tested for normality using Shapiro--Wilk tests. Corticosterone concentrations were logarithmically transformed and analysed using general linear models that allowed for repeated measures. We first tested for differences in plasma concentrations of corticosterone between UC and BC frogs at days −5 and 7 to ensure that blood sampling on day 4 did not affect hormone concentrations in the BC frogs. We then compared circulating corticosterone concentrations in BC and CORT animals at all three time points (days −5, 4 and 7); to interpret a significant interaction term, we used the EMMEANS command in SPSS and a Bonferroni correction for multiple comparisons. Given that we did not sample UC animals on day 4, we omitted them from this analysis. Finally, because we found no significant differences in circulating concentrations of corticosterone between UC and BC animals, we combined these two treatments to increase statistical power and conducted a general linear model (GLM) for the combined control groups vs. the CORT group for days −5 and 7 to test the effect of exogenous corticosterone application on circulating corticosterone concentrations.

Sperm and spleen cell counts were logarithmically transformed prior to analysis to meet the assumption of normality. Sperm-viability data met normality assumptions and were not transformed. Blood-smear data were converted to a ratio of WBCs to RBCs or neutrophils to lymphocytes, square-root transformed, and analysed with Student's unpaired *t*-tests. ANCOVAs were used for all sperm and splenic cell count analyses, with body mass as a covariate. As no significant differences were detected between the UC and BC groups in any of these measures, data from the two control groups were combined for each ANCOVA, and subsequent comparisons were made between control and CORT animals. Data were analysed using SPSS v.21. All tests were two tailed, with a critical *P*-value of 0.05.

Results {#s3}
=======

Plasma corticosterone concentrations {#s3a}
------------------------------------

As expected, the blood-sampled control (BC) and undisturbed control (UC) groups did not differ in plasma corticosterone concentrations on days −5 and 7 of the experiment (*F*~1,5~ = 4.4, *P* = 0.091), nor was a significant interaction between day and treatment found (*F*~1,5~ = 1.6, *P* = 0.25). However, because UC frogs were not sampled on day 4, we did not pool the two control groups for analysis of the effect of corticosterone treatment on circulating corticosterone concentrations.

A repeated-measures GLM using logarithmically transformed circulating corticosterone concentrations, comparing CORT and BC frogs, confirmed that transdermal treatment with exogenous corticosterone every 8 h significantly elevated circulating corticosterone concentrations in male White's treefrogs, as reflected in significant effects of treatment, day of study and day × treatment interaction (treatment, *F*~1,5~ = 12, *P* = 0.016; day, *F*~2,10~ = 18, *P* \< 0.001; and interaction, *F*~2,10~ = 6.9, *P* = 0.013). Within-group planned pairwise comparisons revealed that BC animals had statistically indistinguishable levels of circulating corticosterone across all three time points, whereas plasma corticosterone concentrations in CORT frogs increased significantly across the study (day −5 vs. day 4, *P* = 0.026; day −5 vs. day 7, *P* = 0.003; and day 4 vs. day 7, *P* = 0.004). This divergence is evident when the treatments are compared at each time point; plasma corticosterone concentrations did not differ between groups on day −5 (*F*~1,5~ = 0.10, *P* = 0.76), but were significantly higher in CORT frogs than in control frogs on day 4 (*F*~1,5~ = 12, *P* = 0.017) and day 7 (*F*~1,5~ = 180, *P* \< 0.001; Fig. [1](#COV022F1){ref-type="fig"} and Table [1](#COV022TB1){ref-type="table"}).Table 1:Mean, SEM and sample size for corticosterone, sperm and splenic cell measures as well as average body mass at the end of the study, for each treatment groupParameterExogenous corticosterone (CORT) groupUndisturbed control (UC) groupBlood-sampled control (BC) groupCombined UC and BC groupsPlasma corticosterone (ng/ml), day −54.0 ± 1.8 (*n* = 8)2.7 ± 1.4 (*n* = 4)2.0 ± 0.6 (*n* = 4)2.3 ± 0.6 (*n* = 8)Plasma corticosterone (ng/ml), day 416 ± 4.2 (*n* = 7)n.d.2.0 ± 0.92 (*n* = 5)n.d.Plasma corticosterone (ng/ml), day 727 ± 4.8 (*n* = 9)3.2 ± 0.92 (*n* = 5)6.2 ± 1.1 (*n* = 5)3.2 ± 0.61 (*n* = 10)Sperm count (millions)8.2 ± 1.4 (*n* = 10)7.6 ± 2.3 (*n* = 5)7.3 ± 3.4 (*n* = 5)7.6 ± 2.2 (*n* = 10)Sperm viability (% viable)88.3 ± 1.2 (*n* = 8)88.4 ± 2.1 (*n* = 3)89.5 ± 2.1 (*n* = 5)89.1 ± 1.4 (*n* = 8)Splenic cell count (millions)1.2 ± 0.36 (*n* = 10)3.2 ± 1.6 (*n* = 5)3.1 ± 1.3 (*n* = 5)3.2 ± 1.0 (*n* = 10)Mass (g)34.40 ± 2.436.00 ± 2.334.40 ± 0.2435.20 ± 1.1[^4] Figure 1:Circulating concentrations of corticosterone after transdermal treatment. Transdermal treatment with corticosterone every 8 h increased plasma corticosterone concentrations in White's treefrogs over the course of the study. Shown are back-transformed means ± 95% confidence intervals of circulating corticosterone in treated (CORT) and blood-sampled control (BC) frogs. Asterisks mark time points at which control frogs were significantly different from CORT frogs.

Sperm count and viability {#s3b}
-------------------------

To determine whether treatment with exogenous corticosterone led to a decrease in reproductive function, we measured sperm count and the proportion of sperm that were viable in the right testis of each frog. As previously described, the BC and UC control groups did not differ in any measures of reproductive function (sperm count, *t* = 0.11, d.f. = 8, *P* = 0.91; and sperm viability, *t* = −0.34, d.f. = 6, *P* = 0.75); therefore, data from the two control groups were combined for subsequent analyses. Frogs in the CORT group did not show a difference in sperm count (*F*~3,16~ = 0.73, *P* = 0.55; Table [1](#COV022TB1){ref-type="table"}) or sperm viability (*F*~3,16~ = 1.6, *P* = 0.23; Table [1](#COV022TB1){ref-type="table"}), compared with control frogs. Body mass was not a significant predictor of either sperm count or of sperm viability.

Immune measures {#s3c}
---------------

To determine whether chronically elevated corticosterone concentrations led to suppressed immune function, we phenotyped circulating leucocytes and compared splenic cell counts in frogs that did and did not receive corticosterone treatment. Hormone treatment reduced the ratio of circulating WBCs to RBCs; CORT frogs had significantly lower ratios of eosinophils to RBCs compared with control frogs (BC and UC groups combined; *t* = 3.3, d.f. = 17, *P* = 0.004; Fig. [2](#COV022F2){ref-type="fig"} and Table [1](#COV022TB1){ref-type="table"}). Although lymphocyte-to-RBC and neutrophil-to-RBC ratios did not differ significantly between groups, the lymphocyte ratio tended to be lower in CORT animals (*t* = 1.9, d.f. = 17, *P* = 0.078; Fig. [2](#COV022F2){ref-type="fig"}). We found no effect of treatment on the neutrophil-to-lymphocyte ratio (*t* = 0.41, d.f. = 17, *P* = 0.69).Figure 2:Ratios of white blood cell counts to red blood cells after corticosterone treatment. Back-transformed means and 95% confidence intervals are presented. Asterisks indicate measures that differed significantly between CORT and control (BC and UC combined) frogs.

The BC and UC control groups did not differ in splenic cell count (*t* = 0.39, d.f. = 8, *P* = 0.97); therefore, data from the two control groups were combined for analysis. Splenic cell count was not influenced by corticsterone treatment (*F*~2,17~ = 2.5, *P* = 0.12). Body mass was included in the ANCOVA model but was not a significant predictor of splenic cell count.

Discussion {#s4}
==========

We previously found that chronic (7 day) exposure to an anthropogenic noise stressor elevated circulating corticosterone concentrations and decreased sperm count and sperm viability in captive White's treefrogs ([@COV022C24]). In the present experiment, therefore, we treated treefrogs with exogenous corticosterone for the same duration to determine whether increased corticosterone concentrations might have mediated this stress-induced reproductive suppression and to evaluate possible effects on immune function. Here, we found that despite chronically elevated plasma corticosterone concentrations, neither sperm count nor sperm viability was affected. Indeed, in this study, plasma corticosterone concentrations were elevated to levels that were likely to be supraphysiological (K. Kaiser, unpublished data) and were an order of magnitude above those seen in our previous study ([@COV022C24]). The exogenous corticosterone treatment in the present experiment yielded decreases in ratios of circulating eosinophils to red blood cells, relative to control frogs. No other immune measures differed among treatments.

Studies in many vertebrate taxa have demonstrated a link between chronically elevated corticosterone or cortisol concentrations and reproductive suppression in both males and females ([@COV022C8]; [@COV022C5]; [@COV022C40]). However, chronic increases in corticosterone do not always lead to such changes, and some organisms, potentially including male *L. caerulea*, may be able to decouple the HPA and hypothalamic--pituitary--gonadal axes ([@COV022C1]; reviewed by [@COV022C52]). Alternatively, it is possible that another hormone(s) in the HPA axis, such as corticotrophin-releasing hormone (CRH), endogenous opioids ([@COV022C33]) or adrenocorticotrophic hormone, rather than corticosterone, is responsible for stress-induced reproductive suppression in male *L. caerulea*. The use of exogenous corticosterone in this experiment is likely to have downregulated the HPA axis through negative feedback. Therefore, while it is unlikely that these hypothalamic and pituitary hormones directly suppressed immune measures in this study, we cannot rule out the possibility that reductions in these hormones, rather than or in addition to increases in corticosterone, contributed to our findings. Another caveat to our results is that because of logistical constraints, we did not incorporate a vehicle-treated control group. However, pilot studies suggested that patch application alone did not elicit a stress response (K. Kaiser, unpublished data).

The use of blood smears in the present study allowed us to quantify changes in circulating leucocyte numbers. Only eosinophils, which have been implicated in fighting parasitic infections, such as trematodes ([@COV022C30]; [@COV022C9]), showed significant reduction in CORT animals, though lymphocytes also showed a slight, non-significant decrease. This reduction in eosinophils should be interpreted with caution, because it might have resulted from supraphysiological corticosterone concentrations ([@COV022C24]). In addition, we did not evaluate the functional effects, if any, of chronic corticosterone elevation on the immune system. In multiple species, however, increased glucocorticoid concentrations have been found to be correlated with increased infection rates, suggesting that chronic elevations of corticosterone concentrations may contribute to functional immunosuppression in amphibians as well ([@COV022C15]; [@COV022C18], [@COV022C19]; [@COV022C38], [@COV022C39]).

In conclusion, although stress-induced reproductive suppression is frequently attributed to elevated circulating concentrations of glucocorticoids ([@COV022C5]; [@COV022C37]; [@COV022C31]; [@COV022C52]; [@COV022C43]), we found no evidence for such an effect in male treefrogs. Thus, our findings add to the growing literature suggesting that the interactions of glucocorticoids with reproduction are species specific and complex; effects of these hormones are likely to be not only concentration dependent but also context dependent ([@COV022C42]; [@COV022C31]; [@COV022C52]). Understanding other mechanisms for reproductive suppression may be important in allowing for conservation of threatened species. This is particularly applicable to anurans: although laboratory and wild animals often exhibit different physiological traits ([@COV022C7]), amphibians are increasingly being captive bred in assurance colonies due to global declines.

Nevertheless, chronic increases of circulating corticosterone concentrations in this experiment led to decreased circulating eosinophils, suggesting a possible role for corticosterone and stress in disease- or parasite-related amphibian declines. Because of the potential for such population-level effects due to chronic stress, we suggest that future work should focus on functional assays, such as experimentally determining the effect of corticosterone concentrations on WBCs and infection rates in animals affected by parasites, and understanding the levels of pesticides and/or corticosterone necessary to cause immunosuppression. These results could provide insight into the endocrine correlates of amphibian population dynamics and could prove useful in advancing amphibian conservation.
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